medigraphic.com
ISSN 2225-4676 (Electronic)

2022, Number 2

<< Back Next >>

Rev Cubana Neurol Neurocir 2022; 12 (2)

Acute subdural hematoma in the course of SARS-Cov-2 infection

Varela BAE, Junco GPJ, Martínez SJE, Varela BAV, Pérez OP, Rosales SJD

Language: Spanish
References: 16
Page: 1-11
PDF size: 439.29 Kb.


ABSTRACT

Introduction: The COVID-19 disease displays 15% fatality rate in patients 80 years of age or older. In Italy it reached 52.5% and can increase in the presence of comorbidities. Acute subdural hematoma has a mortality that ranges between 40 and 90%. The coexistence of both conditions constitutes a therapeutic challenge.
Objective: To describe the therapeutic conduct in a patient with acute subdural hematoma in the course of SARS-CoV-2 infection.
Clinical case: We described here the case of an 83-year-old male patient with a history of ischemic cerebrovascular disease, essential arterial hypertension, type 1 diabetes mellitus and SARS-CoV-2 virus infection. During the illness he suffered a fall and later began to present drowsiness and irritability. Acute subdural hematoma was diagnosed and he underwent surgery. The evolution was satisfactory.
Conclusions: Acute subdural hematoma is not a complication of COVID-19, although it poses greater risk to life in these patients. It occurs as an isolated event in patients with risk factors such as high blood pressure, alcoholism, the use of anticoagulant drugs, advanced age and trauma.


REFERENCES

  1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARSCoV-2. Nat Microbiol. 2020 [acceso 13/10/2021];5(4):536-44. Disponible en: https://www.pubmed.ncbi.nim.gov

  2. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020 [acceso 13/10/2021]5;(9):1015-24. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC714275/

  3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 [acceso 13/10/2021];395(10223):507-13. Disponible en: https://www.thelancet.com/journals/lancet/articles/PIIS0140-6736(20)30211-7/fulltext

  4. Parohan M, Yaghoubi S, Seraji A, Hassan M, Sarraf P, Djalali M, et al. Risk factors for mortality in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;8:1-9. Disponible en: https://www.tandfonline.com/doi/full/10.1080/13685538.2020.17774748

  5. Ryan CG, Thompson RE, Temkin NR, Crane PK, Ellenbogen RG, Elmoren JG, et al. Acute traumatic subdural hematoma. J Trauma Acute Care Surg. 2012;73:1348-54. DOI: 10.1097/TA.0b013e31826fcb30.

  6. Tallon JM, Ackroyd-Stolarz S, Karim SA, Clarke DB. The epidemiology of surgically treated acute subdural and epidural hematomas in patients with head injuries: a population-based study. Can J Surg. 2008;51:339-45.

  7. Centre for Evidence-Based Medicine, Kernohan A, Calderon M. What are the risk factors and effectiveness of prophylaxis for venous thromboembolism in COVID-19 patients? 2020 [acceso 21/10/2021]. Disponible en: https://www.cebm.net/covid-19/20200/

  8. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the “cytokine storm” in COVID-19. J Infect. 2020;80(6):607-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC7194613/

  9. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 [acceso 21/10/2021];46(5):846-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/PMC7080116

  10. Agarwal A, Rochwerg B, Lamontagne F, Siemieniuk R A, Agoritsas T, Askie L, et al. A living WHO guideline on drugs for COVID-19. BMJ. 2020 [acceso 22 de octubre de 2021]. Disponible en: https://bit.ly/38khELU

  11. Ng Z, Tay WC, Ho CHB. Awake prone positioning for non-intubated oxygen dependent COVID-19 pneumonia patients. Eur Respir J. 2020 [acceso 02/11/2021]. Disponible en: https://erjournals.com/content/early/2020/05/22/13993003.01198-2020

  12. Moores LK, Tritschler T, Brosnahan S, Carrier M, Collen JF. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST guideline and expert panel report. Chest. 2020 [acceso 02/11/2021]. Disponible en: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1

  13. Recovery Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell J, et al. Dexamethasone in hospitalized patients with Covid-19: preliminary report. N Engl J Med. 2020 [acceso 02/11/2021]. Disponible en: https://www.nejm.org/doi/full10.1056/NEJMoa2021436

  14. Cruz AM, Ugalde A, Aparicio CA, Contreras LY, Carnalla M, Choreño JA, et al, Abordaje del traumatismo craneoencefálico Aten. Fam. 2019;26(1):28-33. DOI: http://dx.doi.org/10.22201/facmed.14058871p.2019.1.67714

  15. Brown DA, Wijdicks EFM. Decompressive craniectomy in Acute Brain Injury, Handbook of Clinical Neurology. Elsevier. 2017 [acceso 02/11/2021];140:299-318. Disponible en: http://pubmed.ncbi.nlm.nih.gov

  16. Tabibkhooei A, Hatam J, Mokhtari M, Abolmaali M. COVID-19 associated spontaneous subacute subdural haematoma: report of two cases. New Microbes New Infect. 2021;40:100848. DOI: http://doi.org/10.1016/j.nmni_2021.100848




2020     |     www.medigraphic.com